Intensive Care Program for Youth With Diabetes
Not Applicable
Completed
- Conditions
- Type 1 Diabetes
- Registration Number
- NCT00961974
- Lead Sponsor
- Joslin Diabetes Center
- Brief Summary
The purpose of this study was to determine the ability of a family-focused, office-based intervention to improve medical and behavioral outcomes for children and adolescents with type 1 diabetes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 154
Inclusion Criteria
- Age 8-16 years
- Type 1 diabetes diagnosed by standard American Diabetes Association criteria
- Type 1 diabetes duration of at least 6 months
- Residence in northeastern U.S.
- Established clinic patient
- Fluency in English or Spanish
Exclusion Criteria
- Major psychiatric disorder (e.g., major depression, severe eating disorder, mental retardation)
- Unstable living environment (e.g., Department of Social Services or Department of Youth Services involvement)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Glycemic control, assessed by hemoglobin A1c Every 3 months
- Secondary Outcome Measures
Name Time Method Psychosocial factors (diabetes-specific family conflict, responsibility-sharing for diabetes management tasks, quality of life, affect regarding blood glucose monitoring, disordered eating behaviors) Annually Weight, assessed by z-BMI (age- and gender-adjusted body mass index) Every 3 months Frequency of hospitalizations, emergency department visits, and episodes of severe hypoglycemia Every 3 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the Care Ambassador Intervention's impact on type 1 diabetes management in pediatric patients?
How does the Care Ambassador Intervention compare to standard-of-care behavioral therapies for youth with type 1 diabetes in terms of glycemic control and adherence outcomes?
Are there specific biomarkers that correlate with improved behavioral and metabolic outcomes in the Psychoeducational Intervention for pediatric type 1 diabetes?
What adverse events were observed in the Joslin Diabetes Center's family-focused behavioral intervention for youth with type 1 diabetes and how were they managed?
What combination approaches or complementary therapies have been evaluated alongside behavioral interventions like the Care Ambassador model for pediatric type 1 diabetes management?
Trial Locations
- Locations (1)
Joslin Diabetes Center
🇺🇸Boston, Massachusetts, United States
Joslin Diabetes Center🇺🇸Boston, Massachusetts, United States